Literature DB >> 28178629

Plasma methionine depletion and pharmacokinetic properties in mice of methionine γ-lyase from Citrobacter freundii, Clostridium tetani and Clostridium sporogenes.

E A Morozova1, N V Anufrieva1, D Zh Davydov2, M V Komarova3, I N Dyakov4, A N Rodionov1, T V Demidkina5, V S Pokrovsky6.   

Abstract

PK studies were carried out after a single i.v. administration of 500 and 1000 U/kg by measuring of MGL activity in plasma samples. L-methionine concentration was measured by mass spectrometry. After single i.v. injection of 500U/kg the circulating T1/2 of enzymes in mice varies from 73 to 123min. The AUC0-tinf values determined for MGL 500U/kg from C. freundii, C. tetani and C. sporogenes are 8.21±0.28, 9.04±0.33 and 13.88±0.39U/(ml×h), respectively. Comparison of PK parameters of three MGL sources in the dose of 500U/kg indicated the MGL C. sporogenes to have better PK parameters: clearance 0.83(95%CI: 0.779-0.871) - was lower than C. tetanii 1.27(95%CI: 1.18-1.36) and C. freundii 1.39(95%CI: 1.30-1.49). Mice plasma methionine decreased to undetectable level 10min after MGL 1000 U/kg injection. After MGL C. sporogenes 500U/kg injection plasma methionine level completely omitted after 10min till 6h, assuming the sustainability of negligible levels of methionine (<5μM) in plasma of mice for about 6h. The recovery of methionine concentration showed the advantageous efficiency of MGL from C. sporogenes: 95% 0.010-0.022 vs 0.023-0.061 for MGL C. freundii and 0.036-0.056 for MGL C. tetani. There are no significant differences between methionine cleavage after MGL C. tetani and MGL C. sporogenes i.v. injection at all doses. MGL from C. sporogenes may be considered as promising enzyme for further investigation as potential anticancer agent.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Methionine depletion; Methionine γ-lyase; Pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 28178629     DOI: 10.1016/j.biopha.2017.01.127

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  Plasma pharmacokinetics and tissue distribution of L-lysine α-oxidase from Trichoderma cf. aureoviride RIFAI VKM F- 4268D in mice.

Authors:  V S Pokrovsky; A N Lukashev; G Babayeva; S Sh Karshieva; A Yu Arinbasarova; A G Medentzev; M V Komarova; E V Lukasheva
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

2.  Methionine gamma lyase from Clostridium sporogenes increases the anticancer effect of doxorubicin in A549 cells and human cancer xenografts.

Authors:  V S Pokrovsky; N Yu Anisimova; D Zh Davydov; S V Bazhenov; N V Bulushova; G B Zavilgelsky; V Y Kotova; I V Manukhov
Journal:  Invest New Drugs       Date:  2018-06-15       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.